losartan-potassium has been researched along with Laron-Syndrome* in 1 studies
1 other study(ies) available for losartan-potassium and Laron-Syndrome
| Article | Year |
|---|---|
IGF-I treatment of patients with Laron syndrome suppresses serum thrombopoietin levels but does not affect serum erythropoietin.
Topics: Adolescent; Adult; Child; Child, Preschool; Erythropoietin; Female; Growth Substances; Humans; Insulin-Like Growth Factor I; Laron Syndrome; Male; Middle Aged; Platelet Count; Thrombopoietin | 2009 |